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ABSTRACT 
 
 
Introduction:  Esophageal atresia (EA), a rare anomaly characterized by a gap within the 
esophageal tract, causes serious complications in newborn infants.  Surgery is the only 
treatment available to cure EA.  This study focuses on Long Gap Esophageal Atresia 
(LGEA) reconstructive surgery using the Foker process for in vivo growth induction of the 
esophagus.  This process incorporates multiple surgeries that take place over a period of 
weeks to months.  Patients undergoing LGEA surgery may be at greater risk for bone 
fracture, due to poor nutritional status, administration of certain medications and 
prolonged periods of immobility.  Other risk factors contributing to bone fragility include 
low birth weight and other congenital anomalies.  This study uses a retrospective 
analysis to determine which variables may contribute to fractures in patients who have 
undergone the Foker procedure. 
 v 
Objectives:  Clinical characteristics (age, gestational age, associated congenital 
anomalies, total Foker surgical procedures, Foker process duration and total days of 
administered paralytics) associated with fractures in patients who underwent the Foker 
procedure were determined. 
Methods: The study compares two groups of surgical patients: patients who sustained a 
fracture in the hospital with those who remained fracture free.  This was accomplished 
through a retrospective analysis study of 41 patients that underwent the Foker Process 
in vivo growth induction surgery.  Mann-Whitney tests, Fisher’s Exact tests or Chi 
Squared tests were used to determine whether a relationship existed between fractured 
patients and the analyzed variables. 
Results:  Out of 41 study participants, 56.1% sustained at least one fracture during their 
hospitalization, 58.5% presented with tracheoesophageal fistula (TEF) in addition to EA, 
48.8 % had preadmission esophageal or gastric surgeries and the mean gestational age 
was 35.8 weeks.  There were no statistical group differences between patient’s age, 
gender, gestational age, total length of stay before patients received a fracture, and 
total days on medications before patients received a fracture.  There was a significant 
difference between the percent of patient’s length of stay (P=0.001), time span of Foker 
procedures (P=0.046), number of Foker surgical procedures (P=0.002), total number of 
Foker 1(P=0.008) and Foker 2 surgical interventions (P=0.032), and the total days on 
parenteral nutrition (P=0.001), paralytics (P=0.003), and loop diuretics (P=0.006).  Most 
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patients received one fracture (60.95%).  Most of the fractures occurred in the right 
humerus (52.2%) and right femur (43.5%). 
Discussion:  This study showed a significant group difference between patient’s length 
of hospitalization, total days on medications, number of Foker surgical procedures and 
preadmission esophageal or gastric procedures.  These variables may contribute to 
fractures.  Fractured patients stay in the hospital for longer periods of time, are 
administered more paralytics and are immobilized for longer durations because their 
surgical cases may be more severe.  This immobilization may increase their risk of 
fractures.  More studies need to be done to confirm this hypothesis.  Potential 
prospective studies aimed at improving the bone health of Foker patients are the 
implementation of physical therapy and the use of bisphosphonates. 
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INTRODUCTION 
Esophageal Atresia 
1.1) What is Esophageal Atresia? 
 Esophageal Atresia (EA) is a rare congenital anomaly of the gastrointestinal 
system that causes serious complications in newborn infants.  It is characterized by an 
incomplete esophageal tube, in which the esophagus does not connect to the stomach.  
The esophagus is a muscular tube that originates in the mouth and propels matriculated 
food, through peristalsis, into the stomach.  EA, the most common anomaly of the 
esophagus (Holland & Fitzgerald, 2010), occurs at an incidence rate of 1 in 2,500 to 
4,500 births (Holland & Fitzgerald, 2010; Kunisaki & Foker, 2012).  If EA is left 
undetected, patients have a mortality rate of 100% because they cannot receive 
nutrition through eating.  In the majority of cases, EA is treated by surgery to 
reconstruct the esophagus. 
 Infants born with EA are unable to eat properly since food cannot pass through 
the esophagus into the stomach.  Until the esophagus is reconstructed, infants with EA 
require feeding through gastrostomy tube, in which formula is directly delivered into 
the stomach to bypass the esophagus, or by parenteral nutrition.  According to Reginald 
Tsang, the preferred route of administration is through eternal nutrition. Parenteral 
nutrition is used when eternal administration is inadequate.  Parenteral nutrition can 
cause major metabolic disturbances, end organ dysfunctions, and nutrient-drug 
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interactions.  There are also long-term complications with enteral nutrition such as: the 
increased incidence of gastro esophageal reflex (GER), hepatic dysfunction, metabolic 
bone disease, and loss of suckle reflex which comprises infant’s oral motor development 
and reduces their ability to control oral intake.  Reginald Tsang also believes oral 
feedings are the preferred method of nourishment because it allows the patient to live 
out a normal life and minimizes the risk of complications (Tsang, 1997).  To achieve this, 
surgery has to be done to reconstruct the esophagus. 
 Depending on the length of the esophageal gap, EA can be classified as Short 
Gap Esophageal Atresia (SGEA), Long Gap Esophageal Atresia (LGEA), and Ultra Long 
Gap Esophageal Atresia (ULGEA).  According to John E. Foker, SGEA is defined as a small 
breach between the two esophageal ends and typically includes TEF.  SGEA occurs in 
around 80% of all EA patients.  The surgical repair for this sized gap is relatively reliable 
and involves an early primary anastomosis of the esophagus.  LGEA, occurs in one out of 
five EA patients (Foker, Kendall, Catton, & Khan, 2005). There is a lack of consensus 
among the medical community regarding the definition of LGEA (Foker et al., 2005; 
Holland & Fitzgerald, 2010; Tovar & Fragoso, 2011).  Tovar and Fragoso propose that the 
challenge in establishing a unified definition lies in the rarity of the anomaly and the 
limited amount of LGEA cases.  Currently, a surgeon’s own experience with EA 
determines their definition on what constitutes a LGEA (Tovar & Fragoso, 2011).  John E. 
Foker defines LGEA as a gap that is 2-3 cm or longer (Foker et al., 2005), while Saud Al-
Shanafey defines it as “an impossible anastomosis”(Al-Shanafey & Harvey, 2008). 
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Another source, describes it as a distance of four or more vertebral bodies, while under 
applied tension (Holland & Fitzgerald, 2010).  Some patients present with even larger 
gaps consisting of 3.5 cm or larger (Foker et al., 2005).  These gaps are considered 
ULGEA.  ULGEA has also been defined as five or more vertebral bodies long (Kunisaki & 
Foker, 2012).  The reliability of LGEA reconstructive repair surgery decreases as the 
length of the gap increases (Foker et al., 2005). 
1.2) Why does Esophageal Atresia Occur? 
 According to Kunisaki and Foker, the developmental aberrations that lead to EA 
occur during the fourth to fifth week of gestation and are not completely understood. 
During this period of fetal development the ventral portion of the foregut gives rise to 
the trachea and lungs, while the dorsal foregut forms the esophagus.  In EA patients, the 
joining of the dorsal and lower esophagus is disrupted, forming an incomplete 
esophagus with a gap between the two ends.  The cause of an esophageal atresia 
malformation is also poorly understood.  However, Kuniaski and Foker suggest that the 
esophageal anomaly may be triggered by a combination of genetic, biomechanical, and 
environmental factors (Kunisaki & Foker, 2012).  Hereditary factors are believed to have 
a minor role in the origin of esophageal atresia, parallel to 1%, although the incidence of 
EA is higher in twins (Holland & Fitzgerald, 2010).  10% of all EA/TEF patients have a 
genetic syndrome such as trisomy 18, trisomy 21, trisomy 13, CHARGE syndrome, 
DIGeorge Syndrome, Geingold Syndrome, Opitz Syndrome, Snophthalamia-Esophageal-
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Genital Syndrome, and Fanconi anemia (Foker et al., 2005; Kunisaki & Foker, 2012).  
These genetic syndromes present with a variety of different anomalies.  Environmental 
factors seem to be more significant at inducing EA and the biomechanical factors 
involved in the formation of an abnormal esophagus are still poorly understood 
(Kunisaki & Foker, 2012). 
1.3) Anomalies Associated with Esophageal Atresia 
 Typically, EA occurs with another anomaly called tracheoesophageal fistula (TEF).  
TEF is characterized as an abnormal connection between the trachea and esophagus.  
The trachea is the tube that connects the mouth with the lungs.  The trachea and the 
esophagus are not physiologically supposed to be joined.  When an individual with TEF 
swallows, food contents can pass into the lungs and cause complications.  There are four 
variants of EA based on the location of the atresia and the presence or absence of a TEF 
(Kunisaki & Foker, 2012).  Around 85% of all EA cases have a distal TEF and a blind-
ending proximal EA (fig A) (Foker et al., 2005; Holland & Fitzgerald, 2010; Kunisaki & 
Foker, 2012)( 18). There are other less common variants of TEF.  These include: EA with 
a proximal and distal TEF (fig C), and a proximal TEF and a distal EA (fig D). The fourth 
variant is an isolated EA without a TEF which is characterized by the presence of both 
esophageal segments ending in a blind pouch (fig B).  Isolated EA occurs in 7-8% of all EA 
cases (18) and typically consists of a large gap length between the esophageal ends 
(Kunisaki & Foker, 2012). An individual can also have an isolated TEF where the 
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esophagus is physiologically normal except for a tube connecting the esophagus to the 
trachea (fig B) (Kunisaki & Foker, 2012).  An isolated TEF is not considered EA. 
 
Figure 1: Variants of EA and TEF. (A) EA with distal TEF (B) Isolated EA (C) EA with distal 
and proximal TEF (D) EA with proximal TEF (E) Isolated TEF (Kunisaki & Foker, 2012). 
 
 EA is usually accompanied with a broad range of additional anomalies.  Over 50% 
of patients present with at least one other anomaly (Holland & Fitzgerald, 2010).  While 
TEF is the most common associated anomaly occurring in 80% of all EA patients, 10-25% 
of all EA patients are born with the VACTERL association.  VACTERL is a nonrandom 
association of birth defects and includes vertebral, anorectal, cardiac, tracheal, 
esophageal, renal, and limb aberrations (Holland & Fitzgerald, 2010; Kunisaki & Foker, 
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2012).  An isolated EA is at the highest risk for VACTERL association (Kunisaki & Foker, 
2012).   Excluding TEF, cardiac defects account for the greatest number of anomalies 
associated with EA patients.  Cardiac defects in EA patients may or may not be a feature 
of the VACTERL association (Holland & Fitzgerald, 2010).  Since polyhydramnios and an 
absent or small stomach are common predispositions of EA, the associated anomalies 
that come with these conditions are also seen in EA patients.  The anomalies that are 
associated with polyhydramnios are listed in the appendix (Houben & Curry, 2008).   The 
associated anomalies that accompany EA, may affect both the patient’s surgical 
treatment plan and outcome (Holland & Fitzgerald, 2010).  
1.4) Diagnosing Esophageal Atresia 
 Currently EA is difficult to diagnose during pregnancy. In a small number (10-
40%) of cases, EA can be detected with an ultrasound (Holland & Fitzgerald, 2010; 
Kunisaki & Foker, 2012).  The most common predisposition of EA is a small stomach 
bubble or an absent stomach accompanied with polyhydramnios (Holland & Fitzgerald, 
2010; Kunisaki & Foker, 2012); however this finding only has a positive predictive value 
of 44% to 56% (Kunisaki & Foker, 2012).  In some EA cases the stomach can also appear 
normal due to gastric secretions filling up the stomach with fluid (Holland & Fitzgerald, 
2010; Kunisaki & Foker, 2012).   The presence of VACTERL association anomalies in 
infants also leads to suspicion of EA/TEF, although at a lower predictive value (Holland & 
Fitzgerald, 2010; Kunisaki & Foker, 2012).   
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 The majority of all EA patients are diagnosed at birth after finding that an 
orogastric tube is unable to pass into the infant’s stomach (Holland & Fitzgerald, 2010; 
Kunisaki & Foker, 2012).  EA is suspected shortly after birth if an infant chokes during 
attempted feeding, is unable to swallow saliva, and has respiratory distress (Holland & 
Fitzgerald, 2010; Kunisaki & Foker, 2012).  More research needs to be done to further 
develop and improve the antenatal diagnostics for EA.  The development of new 
diagnostic techniques to detect EA during pregnancy will allow clinicians the opportunity 
to better prepare for an EA anomaly.  
1.5) Surgical Repair of Esophageal Atresia: History 
 The only treatment available to repair EA is through surgery, unless the patient 
lives off of feeding tubes and parenteral nutrition.  The first EA reconstructive repair 
surgery was performed at the University of Michigan in 1941 by the thoracic surgeon Dr. 
Cameron Height (Foker et al., 2005; Kunisaki & Foker, 2012).  The mortality rates after 
surgery at this time was 30-50% (Holland & Fitzgerald, 2010).  Since the first surgery in 
1941, surgeons have continued to refine and modify the operative approaches used to 
treat EA (Foker et al., 2005; Holland & Fitzgerald, 2010; Kunisaki & Foker, 2012).  Today 
the survival rates of patients who undergo EA/TEF surgery are higher than 98% (Kunisaki 
& Foker, 2012) due to the enhanced surgical techniques and superior neonatal care 
practices (Foker et al., 2005; Holland & Fitzgerald, 2010; Kunisaki & Foker, 2012). 
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1.6) Principles Behind the Surgical Repair of Esophageal Atresia 
 The majority of literature agrees that the most effective EA repair methods use 
the child’s own, native esophagus.  This technique is called a primary repair (Foker et al., 
2005; Holland & Fitzgerald, 2010; Kunisaki & Foker, 2012).  A primary repair also leaves 
the stomach in the abdomen below the diaphragm where it belongs (Foker et al., 2005).  
However, not all experts agree on the best management approach.  For example, T.A 
Tovar, has presented concerns that the esophageal quality after some growth induction 
and anastomosis procedures can be poor, which may cause complications in children 
such as GER, dysphagia, stenosis, chronic respiratory disease and poor esophageal 
motility (Tovar & Fragoso, 2011).  Despite these concerns, the majority of literature 
agrees that a primary anastomosis, in most cases, is the best surgical option available 
(Foker et al., 2005; Holland & Fitzgerald, 2010; Houben & Curry, 2008; Kunisaki & Foker, 
2012). 
 Sometimes a surgeon cannot use the child’s own esophagus.  In these cases 
there are other surgical methods available.  Surgeons can substitute the esophagus with 
different organs by making esophageal grafts.  An esophageal tube can be developed 
from the stomach or colon and then interposed to establish continuity of the 
esophageal (Holland & Fitzgerald, 2010; Kunisaki & Foker, 2012).  However, thse 
methods do not yield results that are as satisfactory as retaining the child’s native 
esophagus (Foker et al., 2005). 
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 Earlier EA repair is also more beneficial.  According to John E. Foker, the best 
time to undergo EA reconstruction surgery is during the newborn period.  Earlier repair 
correlates with a reduction in pulmonary complications, oral aversion, and reduces long 
term medical costs (Foker et al., 2005).  However, when there is a significant distance 
between the esophageal ends, such as in LGEA and ULGEA, early repair is not usually 
conceivable because the esophagus needs time to grow (Kunisaki & Foker, 2012).  
1.7) Surgical Repair Techniques for Esophageal Atresia 
 SGEA reconstructive can be accomplished through a straightforward approach 
with primary repair since the esophagus is close enough together that, with a small 
amount of applied tension, the esophagus can be sutured together in one surgical 
attempt.  LGEA repairs are more difficult to repair because of the large gap distance 
between the two esophageal ends.  With LGEA patients, an early primary repair is 
impossible because the esophageal ends are too far apart to suture them together, even 
with applied tension.  Over the decades numerous surgical approaches have been 
developed to combat this problem such as installing magnetic devices into both of the 
esophageal ends to stimulate growth and inducing serial dilation with bougies (Tovar & 
Fragoso, 2011).  Today the basic approaches used for LGEA repair are Conduit 
Reconstruction, the Collis-Nissen fundoplication and the Foker Process (Kunisaki & 
Foker, 2012).  Other methods, described by Holland and Fitzgerald, include circular or 
spiral myotomies, extensive mobilization of the distal esophagus, and tabularization of 
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an upper pouch flap.  These methods are not as widely accepted (Holland & Fitzgerald, 
2010).   
 Conduit Reconstruction uses an esophageal replacement to establish continuity 
of the esophagus.  It can be achieved through colonic, gastric, or jejunal grafts (Kunisaki 
& Foker, 2012).  Esophageal replacements are accompanied with many side effects that 
require life-long care and monitoring (Cowles & Coran, 2010).  Before choosing an 
esophageal replacement, Kunisaki and Foker believe a primary repair should always be 
considered, even if it means a delayed surgery.  Retaining the native esophagus greatly 
outweighs the benefits of an earlier repair through the interposition of a graft.  
Esophageal replacements are performed at many referral pediatric hospitals worldwide 
and have been used for decades (Kunisaki & Foker, 2012).  Typically this surgery is 
preferred when a delayed primary repair is not possible because the esophageal gap 
length is too large (Holland & Fitzgerald, 2010).   
 The Collis-Nissen fundoplication procedure has also been used for delayed LGEA 
reconstruction surgery (Kawahara, Imura, Yagi, Kubota, & Okada, 2002). As described by 
Hisayoshi Kawahara, the Collis-Nissen procedure is a combination of a Collis gastroplasty 
and a Nissen fundoplication.  Simply put, this technique lengthens the distal esophagus 
until a fundoplication can be accomplished around the distal esophageal end.  There is a 
high rate of gasteroesophageal reflux and esophageal dysmotility accompanied with the 
Collis-Nissen (Kawahara et al., 2002).   
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 The LGEA surgical method that is the focus of this thesis is an in vivo esophageal 
growth induction technique, known as the Foker Process.  This technique induces 
esophageal growth by applying a continual external traction to the esophagus.  Over a 
series of multiple growth induction surgeries that last between a few weeks to over a 
year, surgeons are able to induce esophageal growth until a primary repair can be 
performed, making this method very attractive.  The Foker Process has shown to 
consistently increase both the length and width of the esophagus (Foker et al., 2005).  
Following surgery, esophageal function is adequate for normal diets, although peristalsis 
does not function in the esophageal tract below the primary anastomosis (Foker et al., 
2005).  The Esophageal Atresia Treatment (EAT) Program at Children’s Hospital Boston 
(CHB) is one of the only programs worldwide that uses this technique to treat LGEA.  
The EAT Program also offers care to individuals with other airway problems including 
SGEA, TEF, gastroesophageal reflux, tracheomalacia, laryngeal clefts, and other 
esophageal problems (Boston Children’s Hospital, n.d.).  Patients born with LGEA or 
acquired a LGEA from complications during their primary esophageal surgery at a 
different hospital are referred to CHB from all over the world for treatment.  
1.8) Foker Procedure Steps for Long Gap Esophageal Atresia 
 Initially during surgery, the two esophageal ends are mobilized as much as 
possible without causing damage to the esophagus.  Sutures are then applied to the 
esophageal ends, carefully avoiding the lumen.  The sutures are tied to the esophagus 
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and externalized through the posterior chest wall and tied with tension.  As the 
esophagus grows, tension is reapplied daily to maintain the maximum allowed tension 
to increase the growth rate of the esophagus.  The Foker procedure can be divided into 
three steps; application of traction sutures to induce tension of the esophagus, an 
esophageal anastomosis, and a Nissen Fundoplication, also known as Foker Procedure 1, 
2 and 3, respectively.  Nissen Fundoplication procedures are required in 95% of Foker 
cases (Foker et al., 2005).    
 During the postoperative period, patients are intermittently paralyzed and 
sedated to minimize trauma to the esophageal sutures (Kunisaki & Foker, 2012).  This 
immobilization of the patient prevents swallowing and upward movement of the 
proximal esophagus which reduces the likelihood that the tension sutures will be pulled 
out (Foker et al., 2005; Kunisaki & Foker, 2012).   There is no literature that states the 
exact length of time that these patients are paralyzed; however, observations suggest 
that the time span is between a few weeks to several months.   
1.9) Complications with the Foker Procedure 
 The Foker Process comes with some post-surgical complications.  Severe 
Gastroesophageal Reflex Disease (GERD) and the requirement for endoscopic 
esophageal dilations have been common in patients who undergo the Foker procedure.  
Also, 95% of patients who undergo the Foker Procedure will eventually need a Nissen 
fundoplication to cure their severe GERD (Foker et al., 2005).  Although the Foker 
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Process can cause some medical complication, the procedure offers one vital advantage 
compared to other LGEA surgical reconstruction methods; it preserves the patient’s 
native esophagus (Foker et al., 2005). 
  Ongoing retrospective studies at CHB have noted an incidence of fractures in EA 
surgery patients.  It is not yet known whether these are pre-existing or associated with 
the surgery.  One hypothesis is that the period of post-operative immobility may 
contribute to the suspected increased fracture rates among patients.  Immobilization 
has been shown to cause short term bone resorption and increase the occurrence of 
fractures in patients (Baecker et al., 2003; Huh & Gordon, 2012; Sievänen, 2010).  It has 
been found that during childhood, it is important to increase peak bone mass.  
According to Huh and Gordon, bone density is inversely related to the risk of developing 
bone pathologies later in life.  The need for future studies in this area are critical 
because poor bone health in infancy and childhood may be associated with “lifelong 
bone morbidity” (Huh & Gordon, 2012). 
 This thesis compares characteristics (including: age, gestational age, days on 
paralytics, days on loop diuretics, and days on parenteral nutrition) of patients who 
sustained a fracture during their hospitalization to those who were fracture free to 
determine if any of the variables are consistently associated with the fractured patients.  
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Bone Background 
2.1) Overview of Bone 
 Bone, one of the largest tissues in the body, coordinates and regulates the 
body’s energy metabolism and is a reservoir for essential minerals.  The skeleton is also 
the major support system of the body.  Bone is regulated by several complex and 
intertwined feedback loops between many organs and can be thought of as an 
endocrine system (DiGirolamo, Clemens, & Kousteni, 2012; DiGirolamo et al., 2012; 
Karsenty & Oury, 2012). The bone plays a role in several physiological functions such as 
glucose homeostasis, fertility, and aging (Karsenty & Oury, 2012).  Maintenance of 
proper bone health is important for not only skeletal integrity but also for other 
important physiological functions (Holland & Fitzgerald, 2010).  Many hormones are 
involved in bone maintenance, including parathyroid hormone, calcitonin and active 
vitamin D (1-25 hydroxy vitamin D).  These three major hormones signal to bone cells, 
called osteocytes, to either decrease or increase bone strength.  This process is called 
bone remodeling.   Bone modeling, triggered by the same hormones, also occurs in 
growing skeletons to increase bone length and density.  In addition to hormonal 
regulation, several other factors contribute to proper bone health and maintenance 
including nutritional, behavioral, environmental, and genetic factors (Huh & Gordon, 
2012).  Bone maintenance is a very complicated process that is not yet fully understood.  
More research needs to focus on the skeleton’s role as an endocrine system.  A more 
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complete understanding of how the bone functions as an endocrine system will allow 
for more efficient, effective, and precise medical treatments of not only the bone, but 
the entire body. 
2.2) Bone Remodeling 
 At all ages of life, the human skeleton is constantly being recycled through an 
ongoing process of bone remodeling, which consists of bone formation and bone 
resorption.  The fine balance between bone formation and bone resorption is important 
for repairing damage to the skeleton, ensuring adequate calcium and phosphate 
homeostasis, maintaining bone mass and skeletal integrity, and for linear bone growth 
in children (Karsenty & Oury, 2012).  There are three distinct bone cells that coordinate 
the continuously dynamic state of bone remodeling: osteocytes, osteoclasts, and 
osteoblast (Fricke & Schoenau, 2007).  These cells must perceive and react to the 
external mechanical environment in order to modify their own cellular behavior and 
regulate bone morphology accordingly.  The body has the ability to endure daily stresses 
due to the strong, yet light weight, skeleton created by the continual remodeling of 
bone (Rubin, Rubin, & Jacobs, 2006).  Bone remodeling functions not only for its own 
structure and function, but also for the benefit of the entire body (Holland & Fitzgerald, 
2010).   
 Bone formation is mediated by osteoblasts, which stimulates bone 
mineralization and increases bone density, thereby increasing bone strength. The 
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minerals and hormones needed for bone formation are extracted from the circulation.  
Bone resorption weakens the bones and is mediated by osteoclasts, a cell that 
stimulates the protein matrix of the bone to dissolve.  When bone resorption occurs, the 
demineralized bone particles are picked up by the blood stream and carried throughout 
the body to be used in the body’s metabolic pathways.  Bone remodeling can be altered 
by changing the external mechanical environment around bone cells (Karsenty & Oury, 
2012). 
 Increased mechanical strain on bone cells induces osteoblasts to form new bone.  
For example, a competitive tennis player’s “hitting” arm has 35% thicker cortices than 
the other arm (“Biomechanical aspects of bone formation,” 2004; Rubin et al., 2006).  
This is from the increased stain that the arm receives through hitting the ball.  Disuse of 
bones, such as when patients are immobilized, reduces the stain on bone cells, 
decreases bone formation and stimulates osteoclasts to demineralize the bone 
(“Biomechanical aspects of bone formation,” 2004; Rubin et al., 2006).   The skeletal 
response to bone disuse is more pronounced and occurs at a faster rate, making it 
easier to lose bone than to form it (“Biomechanical aspects of bone formation,” 2004; 
Huh & Gordon, 2012; Sievänen, 2010).   
2.3) What Determines Bone Remodeling? – Mechanosensory Model 
 The bone is equipped with a mechanosensory system, composed of osteocytes, 
which sense the presence or absence of mechanical stain induced on bone and 
regulates bone remodeling accordingly (Huh & Gordon, 2012; Sievänen, 2010).  This 
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system adapts to different mechanical strains and loading conditions to create a 
functionally appropriate skeleton (Hughes & Petit, 2010).  The feedback control system 
pictured in Figure 2 describes the feedback mechanisms of bone remodeling at the 
cellular level (Sievänen, 2010).  The amount of loading, whether its increased or 
decreased, is the driving force for the system and stimulates minute deformations 
within the bone cells.  These deformations are perceived by the “mechanosensory 
system.”  If a stain is perceived to be greater than the mechanosensory “set point” or 
threshold, the osteocyte signals to strengthen the bone so that it will be able to 
withstand the increased stresses.  When this happens, osteoblasts are activated to form 
bone and increase bone durability (Sievänen, 2010).  With a lack of mechanical strain, as 
seen in paralyzed patients, osteocytes signals to reduce bone mass by activating 
osteoclasts to reabsorb bone mineral contents into the bloodstream (Huh & Gordon, 
2012).  Since paralyzed patients are not using their bones, the skeleton does not need to 
be as strong to withstand daily stresses (Sievänen, 2010).  Through the mechanosensory 
system, the body can efficiently distribute its nutrients to areas of the body where they 
are needed the most.   
 The “set point” adapts to the habitual load bearing activities of the body and 
varies at different positions throughout a bone (Sievänen, 2010).  Fractures occur when 
the force exerted on the bone is greater than the “set point” threshold (Huh & Gordon, 
2012).  When bone resorption occurs, this leads to more fragile bones that are more 
prone to fracture.  Other “systemic modulators,” such as genetics, gender, hormones, 
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diseases, nutrition, and age, also contribute to bone remodeling, but the extent to 
which they do is not fully understood yet (Sievänen, 2010).  This system is quite complex 
and involves many cellular, hormonal, and metabolic pathways (Huh & Gordon, 2012; 
Sievänen, 2010). 
 
Figure 2: Mechanosensory System - The mechanosensory system determines if bone is 
in a state of bone resorption or bone formation.  The green arrows represent factors 
that increase bone formation whereas the red arrows represent factors that stimulate 
bone resorption (Sievänen, 2010). 
 
2.4) “Systemic Modulators” Known to be Risk Factors for Bone Resorption and 
Fractures 
 
 Infancy and childhood are considered to be important stages for proper bone 
development.  Bone mass is built during childhood and adolescence, and most people 
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achieve peak bone mass by early adulthood.  Therefore, poor bone development 
occurring during infancy and childhood may lead to lifelong bone morbidity, although 
more research is needed to confirm this.  According to Huh and Gordon, it is important 
to detect all risk factors for poor bone development in young patients and to treat them 
accordingly to optimize their future adult bone health.  Research has shown that bone 
fragility plays a huge role in childhood fractures.   For example, one study, conducted on 
over 6000 children, has shown that fractures are inversely associated with bone density 
(Huh & Gordon, 2012).   
 Certain “systemic modulators” have shown to be risk factors for bone 
demineralization in hospitalized children and increase their risk of fractures.  These 
factors are: preterm birth or a gestational age of less than 37 weeks, poor nutrition, 
gastroesophageal reflux, genetics, underlying medical disorders, a small birth weight, 
and immobilization (Huh & Gordon, 2012).  Specific medications, hormonal 
abnormalities, and nutritional deficiencies listed in Table 1 are also risk factors for bone 
fragility.  Other disease specific “systemic modulators” may also play a role in poor bone 
development such as: low lean body mass, feeding problems, and malabsorption (Huh & 
Gordon, 2012).  Some of the above factors are seen in the Foker procedure patients and 
should be analyzed to determine if they are contributing factors to bone fractures.   
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Medication Glucocorticoids 
Diuretics  
Paralytics 
Anticonvulsants 
Immunosuppressive medications 
Anticoagulants 
Antiretroviral therapies 
Nutritional Deficiencies Low Calcium 
Low Vitamin D 
Low Phosphorus 
Hormonal Abnormalities Parathyroid Hormone 
Vitamin D 
Calcitonin 
 Table 1: Risk Factors for Bone Fragility.  Adapted from Huh SY, Gordan CM: 
Fractures in hospitalized children. Metabolism. 2012 
 
2.5) Immobilization and Bone Mineral Decay 
 One of the “systemic modulators” that has been proven to induce bone 
resorption and reduce bone density is immobilization (Baecker et al., 2003; Huh & 
Gordon, 2012; Sievänen, 2010).  It is well known that decreased bone mass in 
immobilized patients can be significant and occur quickly, though the exact etiology of 
this bone loss is still not well understood and likely involves a combination of factors 
(Stewart, Adler, Byers, Segre, & Broadus, 1982).  It is known that the significant decrease 
in mechanical loading that occurs at the beginning of immobilization is detected by the 
mechanostat “set point” and triggers a decrease in bone formation while bone 
resorption remains relatively unchanged (Sievänen, 2010).  It has also been shown that 
prolonged muscular paralysis, such as in patients with poliomyelitis and spinal-cord 
injuries, cause reductions in bone mass (Stewart et al., 1982).  Several studies have also 
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reported that paralyzed patients have a higher risk of long bone fractures than healthy 
individuals (Sievänen, 2010).   
 There is strong evidence that immobilization induces skeletal mineral loss 
leading to more fragile and fracture prone bones, however it is unclear when this 
deterioration occurs and to what extent.  One study analyzed the effects of bed rest, a 
model of immobilization, on bone resorption (Baecker et al., 2003).  It was a randomized 
crossover study that consisted of two phases.   Eight healthy males were randomly put 
into a six day bed rest period or a 6 day non-bed rest period.  After completion of one 
period, the patients were switched to the opposite phase.  The study controlled the 
patient’s diets, external environment and body movements. The analysis found bone 
resorption, detected by excreted bone resorption markers (C-telopeptide and N-
telopeptide) and urinary calcium excretion levels, to occur as early as in the second day 
of bed rest (Baecker et al., 2003).  This suggests that bone resorption starts as early as 
the second day of bed rest.  More studies need to be performed to confirm this finding 
and to determine the degree of bone resorption that occurs early in immobilization.  
Nevertheless, because immobilization induces bone resorption, measures can be taken 
to reduce the effects that immobilization has on patients.  Several studies have shown 
that physical therapy with medications help to reduce the negative impact 
immobilization has on patients’ bone health (Sievänen, 2010).  
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  Patients undergoing the Foker procedure require prolonged treatment with 
paralytics over the course of their hospitalization.  This thesis describes in detail the 
clinical characteristics of the patients undergoing the Foker procedure, along with 
details of their surgical treatments and hospital course.  Data include the number of 
days treated with paralytics, total duration of immobilization, and other important 
clinical characteristics to determine if the induced state of immobilization might play a 
role in the patients’ bone health and fracture risk.  These results yield important 
information, particularly because Harri Sievänen, along with other researchers, have 
suggested that the strongest determining factor of bone mineral loss is the total 
duration of bone disuse.  With this in mind, the primary goal of this analysis is to 
compare the total duration of paralytics administered in patients who sustained a 
fracture during their Foker procedures to those who were fracture free. 
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NEED FOR STUDY 
 Through ongoing studies at CHB, an incidence of fractures has been detected in 
EA surgery patients.  A CHB in-house, IRB approved, unpublished retrospective study 
titled, “Prompting Bone Health in Esophageal Atresia Patients Paralyzed and Sedated 
Post-Operatively During Esophageal Growth Induction Using the Foker Process,” 
reported that over half of Foker procedure patients sustained at least one fracture 
during their hospitalization.  The Principle Investigator of the study is Dr. Russell 
Jennings.  It is currently unknown whether these fractures are pre-existing or associated 
with the surgery.  One standing hypothesis is that the fractures are induced by the 
patient’s prolonged state of post-operative immobilization.  This thesis project uses the 
retrospective data to begin to better understand the variables that contribute to bone 
fractures in these patients.   
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OBJECTIVES 
 The purpose of this study is to determine the percent of patients who sustained 
a bone fracture over the course of their hospitalization after undergoing the Foker 
procedure, and to characterize variables that may contribute to the fractures observed 
in these patients.  Specifically, this thesis compares different variables between patients 
who sustained a fracture during their Foker procedures to those who were fracture free.  
Any differences found between these two study groups will provide a guide to the 
variables that may contribute to these infant’s fractures.  The data presented in this 
study will guide the development of future retrospective studies focused on identifying 
patients at risk for fragility fractures and understanding clinical characteristics that 
affect bone health.   It will also guide the development of future prospective studies 
focused on improving the bone health of patients who undergo the Foker Process for EA 
reconstructive surgery.   
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METHOD 
 This study reports on patients from an IRB approved study through the EAT 
program at CHB.  The titled of the study is, “Prompting Bone Health in Esophageal 
Atresia Patients Paralyzed and Sedated Post-Operatively During Esophageal Growth 
Induction Using the Foker Process.”  The Principle Investigator of the study is Dr. Russel 
Jennings, MD.  This study‘s aim is to collect and analyze retrospective and prospective 
data on patients treated at CHB for EA anomalies in order to better understand the 
variables affecting patient’s bone health.  With this information, EAT will develop better 
standard of care practices to improve patient’s bone health and lessen the incidence of 
fractures.  This study, supervised by Dr. Eugene Goldfield, PhD, focuses on the data from 
41 patients who underwent EA growth induction surgery by the Foker Process technique 
between the years 2004 and 2013.  An Endocrinologist working on the EAT study, Dr. 
Mellissa Putman, MD, also aided as an informal thesis supervisor.   The thesis study has 
Institutional Review Board approval from CHB to use the amended retrospective data 
for the purpose of this thesis.  Retrospective analysis will be conducted on the 41 
patients to suggest characteristics that may contribute to the observed fractures. 
5.1) Data Collection 
 A list of 42 patient’s Medical Record Numbers (MRN) who underwent the Foker 
Process between the years 2004 and 2013 was obtained from the EAT Program at CHB.  
All data was collected from CHB’s electronic medical records (PowerChart).  The leading 
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Endocrinologist on the study, Melissa Putman, MD, supervised the data collection.  The 
data includes information on demographics, associated anomalies, pregnancy 
complications, past family history, Foker procedures, medications administered, and 
fractures sustained during the patient’s hospitalization stay.  Additional data was 
collected, but is not pertinent to this study.   
 While pulling data from PowerChart, we developed a database to hold the 
collected information.  This step was also supervised by Melissa Putman, MD.  We used 
a database system called Research Electronic Data Capture (RedCap), which is a secure 
internet based application that allows researchers to build, manage and capture data 
(Harris et al., 2009).  After all the data was collected and rechecked for errors, we 
entered it into the database. 
5.2) Inclusion Criteria for Thesis Study 
 For this thesis study, we incorporated only the patients who had the majority of 
their Foker procedures performed at CHB.  Out of the 42 patients, 41 fit this criterion.  
One patient was excluded from the analysis because the majority of his or her 
procedures were performed at Fairview Hospital in Minnesota.  The patient only had a 
Foker 3 redo procedure at CHB.  All other patients were included in the study.  
 Next we exported the 41 patient’s data from the RedCap database into SPSS to 
be analyzed.  Table 2 depicts the variables reported in this study.  Gestational age, loop  
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Demographics Gender 
 Gestational age (weeks) 
 Multiple births 
 Age patient had their first Foker procedure (days) 
 Pregnancy complications 
 Associated congenital anomalies 
 Gap length (cm) 
 Pre-admission esophageal or gastric surgeries 
 Pre-admission fracture 
Admission Information Mean Length of Stay  
 Total Number of Foker Interventions 
 Time Span of Foker Procedures 
 Number of Foker 1 Interventions 
 Number of Foker 2 Interventions 
 Number of Foker 3 Interventions 
Medications (Paralytics, 
Loop Diuretics, Parenteral 
Nutrition) 
Total days on medication throughout hospitalization 
or prior to observed fracture 
 Total days on medication throughout hospitalization  
 
Table 2: Data Collected from EA Patient Charts. Summary of the data extracted from 
patient charts including demographics, admission information and inpatient 
information. 
 
diuretics, parenteral nutrition and paralytics were chosen variables to be analyzed 
because studies have shown them to contribute to fractures (Huh & Gordon, 2012).  
Gender and age were chosen as variables to determine if basic demographics 
contributed to the development of bone fractures in these patients.  We also decided to 
analyze associated congenital anomalies and patient’s esophageal gap size to determine 
if these factors also contribute to fractures.  Once all necessary information was pulled, 
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we divided the patients into three groups: “All Patients,” “Fractured Patients,” and 
“Non-Fractured” patients.  The “Fractured Patients” sustained a fracture during their 
hospitalization stay while the “Non-Fractured” patients did not.  
5.3) Statistical Analysis  
 After the data was collected and exported it into SPSS.  The “All Patients” group 
was analyzed with basic descriptive statistics to gain a general idea of the characteristics 
associated with EA patients that undergo the Foker procedure at CHB.  We compared 
the differences between fractured patients to non-fractured patients using Mann-
Whitney Test for continuous measures and Fischer’s Exact Test or Chi Square Test for 
discrete variables.  The criterion for statistical significance was P < 0.05.  All 
computations were performed with SPSS software. 
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RESULTS 
 
 Table 3 summarizes Foker procedure patient’s basic demographic information.  
The majority of patients were singletons (87.8%) and 51.2% of patients were male.  The 
mean gestational age of patients was 35.8 weeks.  Over half the patients (63.4%) were 
born with polyhydraminios, 58.5% of the patients were born with TEF in addition to EA 
and almost half of the patients had three or more congenital anomalies (46.3%).  Only 2 
out of the 41 patients sustained a fracture prior to their admission to CHB and 48.8% of 
patients had preadmission esophageal or gastric surgeries. 
 Table 4 presents the patient’s Foker procedure surgical characteristics.  Over half 
the patients sustained at least one fracture during their CHB hospitalization (56.1%).  
The mean time span of their Foker procedures (178.83  ± 298.63 days) was a little less 
than their mean length of stay (198.83 ± 148.4 days).  The mean number of Foker 1 
surgical interventions was 2.10.   Whereas the mean number of Foker 2 and Foker 3 
surgical interventions were less than one.  Patients averaged the most days on loop 
diuretics (77.34 ± 105.3) and the least mean amount of days on paralytics (50.74 ± 36.3).  
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Table 3: Summary of All Foker Procedure Patient’s Demographic Characteristics.   
Demographic Characteristics (N = 41) Mean ± SD or N (%) 
  
Gender:                                                           Male 
                                                                          Female 
21 (51.2) 
20 (48.8) 
Gestational Age (weeks) 35.76  ± 3.1 
Multiple Births:                                             Singleton 
                                                                          Twin 
                                                                          Triplet 
36 (87.8) 
4 (9.8) 
1 (2.4) 
Gap Length (cm) (35)1 4.981  ± 1.5 
Pregnancy Complications:                            
     None 
     Polyhydramnios  
     Maternal Hypertension 
     Premature Rupture of Membranes (PPROM) 
     Other2 
 
9 (22.0) 
26 (63.4) 
3 (7.3) 
3 (7.3) 
9 (22.0) 
Congenital Anomalies:                                 TEF 
                                                                          Renal/GU 
                                                                          Cardiac 
                                                                          VACTRL/VATER3 
                                                                          Craniofacial 
                                                                          Trisomy 21 
                                                                          Other4 
 24 (58.5) 
17 (41.5) 
17 (41.5) 
13 (31.7) 
7 (17.1) 
5 (12.2) 
17 (41.5) 
Number of Additional Anomalies:            None 
                                                                          One 
                                                                          Two 
                                                                          Three or More 
2 (4.9) 
8 (19.5) 
11 (26.8) 
19 (46.3) 
Pre-admission fracture  2 (4.9) 
Prior Esophageal or Gastric Surgeries5 20 (48.8) 
1 6 patients did not have a recorded gap length in their medical records 
2 Other pregnancy complications included: maternal diabetes, IUGR/SGA, pre-eclampsia, 
anemia, hydronephorsis, fetal bradycardia, Herpes (HSV), Infant with respiratory distress 
3 VACTRL/VATER association is defined by the presence of at least three of the following 
anomalies: vertebral defects, anal atresia, cardiac defects, TEF, renal anomalies, and limb 
abnormalities 
4 Some of the other congenital anomalies included: Tethered Cord, Scoliosis, and 
extremity, central nervous system, larynx, vertebrae, and eye abnormalities 
5 Prior esophageal surgeries include prior Foker attempts, TEF repairs, esophagus 
anastomosis and stent placements and fundoplication, split fistula and colonic 
interposition 
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Surgery Characteristics (N = 41) Mean ± SD or N (%) 
  
Patient Sustained a Fracture  23 (56.1) 
Mean Length of Stay (days) 198.83 ± 148.4 
Total Number of Foker Interventions 5.49 ± 2.63 
Time Span of Foker Procedures (days) 176.68 ± 298.63 
Number of Foker 1 Interventions 2.10 ± 2.36 
Number of Foker 2 Interventions 0.28 ± 0.65 
Number of Foker 3 Interventions 0.30 ± 0.76 
  
Total Days on Loop Diuretics (days) (38)4 77.34 ± 105.3 
Total Days on Paralytics (days) (38)4 50.74 ± 36.3 
Total Days on PN (days) (38)4 75.89 ± 50.3 
  
4 3 patients medication histories were not available through PowerChart 
Table 4: Summary of All Foker Procedure Patient’s Surgical Characteristics.   
 Demographic and surgical data was compared between fracture and fracture 
free patients in Table 5.  There were no statistical group differences between patient’s 
age, gender, gestational age and gap length.  Singleton, twin and triplet births also 
showed no statistical significant difference between groups.  There was also no 
significant difference between fracture free patient’s length of stay and the length of 
stay before patients received a fracture.  The total days that paralytics, loop diuretics 
and parenteral nutrition were administered in fracture free patients were not 
statistically different from the total days fracture patients were administered the 
medications before they received a fracture. 
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 There was a significant statistical group difference between the percent of 
patients who had preadmission esophageal or gastric surgeries (P=0.017).  65.21% of 
fractured patients had esophageal or gastric surgeries prior to arriving at CHB while 
27.78% of fracture free patients had prior surgeries.  For patient’s total length of stay at 
CHB, there was a statistically significant relationship between groups (P=0.001).  
Fractured patients averaged 246.83 (± 148.12) days while non-fractured patients 
averaged 137.50 (± 127.68) days.  Fracture free patient’s averaged a 188.56 day time 
span between their 1st Foker surgical procedure and their last procedure while fractured 
patients had a 167.43 day time span between procedures.  This relationship was 
statistically significant between groups (P=0.046).  
 The total number of Foker surgical procedures was significantly different 
between groups (P=0.002); fractured patients averaged 6.57 (± 2.84) surgical 
procedures and non-fractured patients averaged 4.11 (± 1.53) procedures.  The total 
mean number of Foker 1 surgical interventions (P=0.008) and Foker 2 surgical 
interventions (P=0.032) were also significantly different between groups. Fractured 
patients averaged 2.96 Foker 1 interventions and 0.43 Foker 2 surgical interventions.  
Non-fractured patients averaged 1.00 Foker 1 surgical interventions and 0.06 surgical 
interventions. The mean total days on loop diuretics (P=0.006), paralytics (P=0.003) and 
parenteral nutrition (P=0.001) also showed to be significantly different.  Fractured 
patients averaged 63.09 days on paralytics, 96.57 days on parenteral nutrition and  
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 (N)1 Mean ± SD  
Characteristics Non-Fracture 
Patients 
N = 18 
Fracture Patients 
N = 23 
P 
    
Age (days) 524.89 ± 1338.65 203.65 ± 157.64 0.2991 
Gender                      Male 
                                    Female 
8 (44.44) 
10 (55.56) 
13 (56.52) 
10 (43.48) 
0.443 
Gestational Age (weeks) 35.33 ± 3.16 36.09 ± 3.01 0.4661 
Multiple Births        Singleton 
                                    Twin or Triplet 
16 (88.89) 
2 (11.11) 
20 (86.96) 
3 (13.04) 
0.6192 
Gap Length (15)3 4.82 ±  0.92 (20)3 5.10 ± 1.79 0.8271 
Prior Esophageal or Gastric Surgeries 5 (27.78)4 15 (65.21) 0.0175 
    
Length of Stay 
       (Discharge Date  - Admissions Date) 
137.50 ± 127.68 246.83 ± 148.12 0.0011 
Length of Stay Prior to Fracture 
       (Fracture Date - Admissions Date) 
 111.43 ± 108.53 0.1311 
Foker Procedure Time Span 188.56 ± 432.6 167.43 ± 131.7 0.0461 
Total Number of Foker Interventions 4.11 ± 1.53 6.57 ± 2.83 0.0021 
Number of Foker 1 Interventions 1.00 ± 1.28 2.96 ± 2.67 0.0081 
Number of Foker 2 Interventions 0.06 ± 0.236 0.43 ± 0.79 0.0321 
Number of Foker 3 Interventions 0.22 ± 0.548 0.35 ± 0.89 0.8371 
    
Days on Loop Diuretics (15)6 30.20 ± 38.55 108.09 ± 123.31 0.0061 
Days on Loop Diuretics Prior to Fracture  52.57 ± 64.57 0.1401,7 
Days on Paralytics (15)6 31.80 ± 17.34 63.09 ± 40.21 0.0031 
Days on Paralytics Prior to Fracture  41.74 ± 27.13 0.3891,7 
Days on PN (15)6 44.20 ± 14.40 96.57 ± 54.62 0.0011 
Days on PN prior to Fracture  55.43 ± 44.00 0.9501,7 
    
1 Compares fracture and non-fracture groups by the Mann-Whitney Test 
2 Compares fracture and non-fracture groups by the Fisher’s Exact Test 
3 6 patients did not have a recorded gap length in their medical records 
4 Prior esophageal surgeries include prior Foker attempts, TEF repairs, esophagus anastomosis 
and stent placements and fundoplication, split fistula and colonic interposition 
5  Compares fracture and non-fracture groups by the Chi-Squared Test 
6 3 patients medication records were not available through PowerChart  
7 Compares non-fractured patient’s total days on medications to fractured patients total days on 
medication prior to their observed fracture 
Table 5: Comparing Demographic and Surgical Characteristics Between Fracture 
Patients and Fracture Free Patients.    
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108.09 days on loop diuretics while fracture free patients averaged 31.80 days on 
paralytics, 44.20 days on parenteral nutrition and 30.20 days on loop diuretics.   
 Table 6 describes the observed bone fracture characteristics in the 23 fractured 
patients.  The majority of patients received one fracture (60.95%).  Most of the fractures 
were sustained in the right humerus (52.2%) and right femur (43.5%).  Fractures were 
also observed in the left humerus (7), left femur (2), left radius (1), hip (1) and hand (1). 
Fracture Characteristics N (%) 
  
Number of Fractures Found:                One 
                                                                    Two 
                                                                    Three 
14 (60.9) 
7 (30.4) 
2 (8.7) 
Location of 
Fractures:            
Humerus:        
 
Femur: 
 
Radius: 
Hip 
Hand: 
Left 
    Right 
    Left 
    Right 
    Left 
 
    Left 
7 (30.4) 
12 (52.2) 
2 (8.7) 
10 (43.5) 
1 (4.3) 
1 (4.3) 
1 (4.3) 
Table 6: Fracture Characteristics. Summary characteristics of the fractures observed in 
Foker Procedure patients. 
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DISSCUSION 
 This study was designed primarily to evaluate characteristics of patients who 
undergo the Foker process, at CHB, for the treatment of EA and also to identify some of 
the variables that may be contributing to the incidence of fractures in Foker procedure 
patients.  This study identified fractures in over half of the patients (23/41).  It is critical 
to understand the factors that influence these fractures because poor bone 
development in children can lead to lifelong bone complications such as osteoporosis 
and increased fracture risk (Huh & Gordon, 2012).  Future studies need to focus on 
understanding the characteristics involved in these fractures.  They also need to focus 
on implementing new standard of care practices to improve the bone development in 
Foker patients in order to decrease their incidence of fractures. 
Summary of Results 
 The study reported a mean gestational age of 35.76 weeks which suggests that 
most patients were born prematurely.  Premature births are characterized by a 
gestational age of less than 38 weeks.  The majority of patients were singletons (87.8%) 
while 9.8% were twins.  In 2009, the twin birth rate in the United States was 2-4% 
(Ananth & Chauhan, 2012).   More than 4% of the Foker patients were twins.  This 
finding may suggest that there is a higher incidence rate of EA in twins, like Holland and 
Fitzgerald advocated.  More research needs to be done to confirm this.  The average gap 
length was 4.981 cm long, suggesting that most of the Foker patients had a ULGEA.  
ULGEA has been characterized as having a gap length of 3.5 cm or longer (Foker et al., 
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2005).  Over half the patients (63.4%) were born with polyhydramnios; this value was 
not surprising since polyhydramnios accompanied with a small stomach bubble is the 
most common predisposition of EA (Holland & Fitzgerald, 2010; Kunisaki & Foker, 2012).   
 The most common additional congenital anomaly in all EA patients was TEF, at 
an order of 58.5%.  At first glance, this value does not appear to correlate with the 
reported 92-93% of all EA cases that should present with TEF (Kunisaki & Foker, 2012).  
However the gap length that typically occurs with isolated EA tends to be greater than 6 
cm in length and larger than the gap length associated with patients presenting with 
both EA and TEF (Coran, 1994).   Patients who come to CHB for treatment of EA typically 
have larger gap lengths which may correlate with more Foker procedure patients having 
isolated EA.  These reasons may explain why there is a higher percent of isolated EA 
cases in our sample compared to all EA patients.  Patients presenting with EA and TEF 
tend to have a smaller gap size and probably do not need to undergo the innovative 
Foker procedure.  These patients can have a primary repair without espophageal 
lengthening because their esophageal ends are close enough.  These primary repair 
procedures are performed at numerous hospitals all over the world.  The second most 
common anomalies found in all EA patients were renal or gastrourinary and cardiac 
abnormalities.  This finding agrees with literature since Holland and Fitzgerald stated 
that cardiac anomalies were the second most common anomaly found in EA patients 
(Holland & Fitzgerald, 2010).  Most of the patients (30/41) had two or more congenital 
anomalies in addition to EA.   Literature states that over 50% of all EA patients present 
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with at least one additional anomaly, so this finding also agrees with literature (Holland 
& Fitzgerald, 2010).  Overall our data regarding patient’s demographical characteristics 
is consistent with data presented in other studies. 
 Over half (54.8%) of all the EA patients in the study sustained at least one 
fracture during their hospitalization.  The patients averaged 5.49 Foker procedure 
surgical interventions, which includes their initial Foker 1, 2 and 3 procedures.  This 
means patients averaged 2.49 additional surgical interventions.  Most of these 
additional procedures were Foker 1 surgical interventions.  The larger number of Foker 1 
interventions may be due to the fact that these patients need to undergo multiple 
traction surgeries in order to lengthen their esophagus.  These lengthening procedures 
are considered Foker 1 procedures.  The patients spent more days on loop diuretics 
(77.34 days) than the other two medications.  Patients spent 75.89 days on parenteral 
nutrition and 50.74 days on paralytics.  
 We found that the patient’s age, gender, gap length and gestational age had no 
statistical significant difference between groups.  It was especially interesting to note 
that gap length and gestational age appeared to have no impact on fractures.  One 
would suspect that a bigger gap length would correlate with fractures because the 
surgical interventions would be more complex, however this is not the case.  Huh and 
Gordon state that premature infants are more prone to fractures.  However, in the case 
of EA patients, prematurity or gestational age does not seem to impact the occurrence 
of fractures in Foker patients.  Whether the patient had multiple birth siblings also did 
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not show a significant difference between fracture and non-fracture groups.  However, 
due to the samples small size, this and the other preceding reports are not that reliable.  
To confirm these reports, larger studies need to be done.   
In this study, the findings indicated that patients with preadmission esophageal 
or gastric surgeries may be more likely to sustain bone fractures (P=0.017).  We also 
noted that the mean length of stay between groups was significantly different 
(P=0.001).  Patients who sustained a fracture during their hospitalization stay had a 
mean length of stay of 109.33 days longer than fracture free patients.  There was also a 
significant group difference between the mean number of total Foker surgical 
procedures, Foker 1 surgical interventions and Foker 2 surgical interventions.  Fracture 
patients averaged more surgical interventions than fracture free patients.  Fractured 
patients also were administered loop diuretics, paralytics and parenteral nutrition for 
more days than fracture free patients (p=.006, p=.003, p=.001; respectively).  Non-
fractured patients were administered medications between 41.74 – 55.43 days where as 
fractured patients were administered medications between 63.09 – 108.09 days.  This 
finding is logical because the more surgical procedures a patients has probably 
correlates with a longer hospital stay and more days on administered medications. 
All of these findings advocate that fractured patients had the more problematic 
surgical cases than fracture free patients, which required the fractured patient to 
undergo more surgical procedures and also stay in the hospital longer.  Conversely, it is 
interesting to note that the more “complicated” surgical cases did not correlate with a 
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larger gap length; there was no statistical mean difference between fractured and non-
fractured patients.  More studies need to be done in order to determine how and to 
what extent these variables play in patient’s bone health.   
 Patients with fractures seem to have longer hospitalization stays and are 
administered paralytics for more days than fracture free patients.  This finding proposes 
that the period of post-operative immobility, induced by the paralytics, contributes to 
the fractures seen in these patients.  Immobilization tends to weaken bones leading to 
an increased risk of bone fractures (Baecker et al., 2003; Huh & Gordon, 2012; Sievänen, 
2010; Stewart et al., 1982).  This hypothesis is strengthened when we look at when the 
fractures occur.  Clinical staff at CHB discovered fractures in patients shortly after were 
taken off paralytics suggesting that it is during this period, as the patients start moving 
their bodies, when fractures are more likely to occur. More research needs to be done 
to determine if this hypothesis is correct and to determine if, how and to what extent 
paralytics influence fractures in these patients.  The other administered medications, 
loop diuretics and parenteral nutrition, are also likely to play a role in patient’s bone 
health, but to a lesser degree.   Both loop diuretics (Huh & Gordon, 2012) and parenteral 
nutrition (Klein & Coburn, 1984) have been shown to be a risk factors for bone fragility.  
Measures should be taken to decrease the total days on these medications and to 
minimize the negative impact that immobilization has on bone health.   
 Most of the fractures were found in the humerus (52.2%) and the right femur 
(43.5%).  Most of the patients (60.9%) only sustained one bone fracture; however some 
 40 
patients sustained two or three.  Interestingly, most fractures occurred in the 
extremities.  The reason why these fractures occurred in the extremities is unknown.  
More research needs to be done to determine this. 
Limitations and Strengths  
A limitation of this study is the small sample size (N=41) encompassing a diverse 
group of patients.  39 of the 41 patients ranged from 1-654 days in age, with two 
patients 4.40 and 15.56 years old.  The patients had a broad range of pre-admission 
histories; 20 had prior esophageal or gastric surgeries, 5 had Trisomy 21, and 13 had 
either VACTRL or VATER syndrome.  The patient’s also had a wide range of gap lengths 
ranging from 2.7-10.0 cm.  The diverse sample group did not make for a contingent 
analysis.  The study calculated large standard deviations from the mean which indicated 
that the data was widely dispersed.  However, because we incorporated 41 out of the 
42 patients, we were able to summarize the characteristics found in all patients who 
came to CHB for EA Foker repair surgery.  This was one of study’s strengths.  The study 
was also able to pinpoint several variables that may be influencing bone fractures in 
Foker patients.   
When CHB started offering the Foker process back in 2004, medical personnel 
were not examining patients for bone fractures as closely as they are now.  This is 
another limitation of the study because some of these earlier patients may have had 
bone fractures that were never identified.  The statistical analysis used in this study for 
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continuous variables is another limitation.  We used Mann-Whitney tests to compare 
variables between fracture and fracture free patients.  Using a more precise statistical 
test is needed for more accurate interpretation.   
A limitation of this retrospective analysis is that the study relied on the accuracy 
of preexisting medical records.  As with all retrospective chart reviews, there is the 
potential for incorrectly entered data and missing information from the medical records.  
In 2004, when the first patient underwent the Foker process at CHB, the hospital did not 
use PowerChart as their medical record system.  This means that some of the earlier 
patients, who had their medical files transferred over to PowerChart, might have lost 
some of their data in the transfer.  Data that is known to be missing from the medical 
chart records and was not included in this study are total days of administered 
medications and gap lengths.  On the other hand, a retrospective study allowed us to 
collect information on a rare set of patients and to establish baseline characteristics of 
CHB Foker procedure patients.  These are two noteworthy strengths of the study.  
Future studies can compare their data to these baseline values and characteristics.   
Future Areas of Research 
Future studies are needed to better understand the characteristics involved in 
the fractures observed in Foker procedures patients.  This study determined if Foker 
procedure patient’s demographic and surgical characteristics differed between fracture 
and fracture free patients and suggested some of the variables that may be contributing 
the observed fractures in these patients.  Even though this thesis provided a hypothesis 
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to why these fractures are occurring, more controlled research needs to be done to 
determine if this hypothesis is correct. 
Measures should be taken to prevent some of the negative effects 
immobilization has on Foker procedure patient’s bone health.  Immobilized patients lack 
the low-level muscle and bone movements that occur in normal activity.  This lack of 
movement leads to a reduced state of mechanical loading and a decrease in bone 
formation.  LC Fritton proposes that frequent daily behavior, such as maintaining 
posture, standing and stretching, are strong determinants to skeletal morphology.  
These behaviors activate frequent low-level muscle and bone movements which are 
thought to contribute to bone remodeling (Fritton, Rubin, Qin, & McLeod, 1997).  One 
way of mimicking these movements in immobilized patients is through continuous 
passive motion therapy (CPM).  It has been shown that CPM may reduce the negative 
impact immobilization has on bone health (Loitz, Zernicke, Vailas, Kody, & Meals, 1989). 
Future prospective studies should look at implementing physical therapy, specifically 
continuous passive motion (CPM), into Foker procedure patient’s standard of care 
practices. 
Future prospective studies aimed at reducing the incidence of fractures found in 
Foker procedure patients should also look at implementing Bisphosphonates into 
patient’s standard of care practices to help reduce the rate of bone resorption.  
Bisphosphonate have been found to decreases bone resoprtion by inhibiting 
osteoclasts.  The medication has been administered to adults for the treatment of 
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osteoporosis for a long time and proved to be extremely effective at increasing bone 
strength.  Several studies have shown bisphosphonates to both increase bone density 
and reduce the risk of fractures (McClung et al., 2013).  Even though bisphosphonates 
work extraordinary well at decreasing bone resorption, there are some important 
questions that need to be addressed before the drug is further considered for 
prospective studies.  First, the drug is incorporated into the skeleton where it remains 
active for years, even after a patient stops taking the drug.  The side effects of this, if 
any, are still unknown.  Secondly, the long-term adverse effects of bisphosphonates are 
still unknown.  Some publications have observed possible links between 
bisphosphonates and osteonecrosis of the jaw, atrial fibrillation and atypical femur 
fractures  (McClung et al., 2013).  Thirdly, bisphosphonate’s efficacy and safety in 
children and adults are still unresolved (Cundy, 2012).  
In children, it is still unknown if the benefits of bisphosphonates outweigh the 
adverse effects.  Currently the drug is only administered to children with severe 
osteogenesis imperfect.  Without administered bisphosphonates, these individuals 
would have externally high risks for developing bone fractures, bowed legs, bone pain 
and scoliosis (“Osteogenesis imperfecta,” 2011; Yamashita, 2010).  Osteogenesis 
imperfecta is a hereditary disease that causes extremely fragile bones (Yamashita, 
2010).  Bisphosphonate therapy helps relieve these symptoms and increase the strength 
and density of bones (Yamashita, 2010).  More studies need to be conducted to 
determine if bisphosphonates are appropriate to use in children.  This ambiguity needs 
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to be addressed before bisphosphonates are incorporated into prospective studies 
because Foker procedure patients are typically children. 
Conclusions 
 In addition to summarizing the characteristics found in Foker procedure patients, 
this study also characterized some the variables that may be associated with fractures 
such as: length of hospitalization stay, total days on medications, number of Foker 
surgical procedures and preadmission esophageal or gastric surgical procedures.  One 
hypothesis is that patients with fractures have complicated surgical cases which cause 
them to stay in the hospital longer and undergo more surgical procedures than fracture 
free patients.  The more surgical procedures a patient has correlates with a longer 
period of immobilization.  Patients have to be post-operatively immobilized to prevent 
their traction sutures from being pulled out.  It may be this increased period of 
immobilization that stimulates bone resorption, leads to poor bone development and 
causes fractures in these patients.  The findings in this study, agree with this hypothesis, 
however more research needs to be done to determine the exact relationships between 
these characteristics and Foker patient’s bone health.   To reduce the impact 
immobilization has on bone health, physical therapy should be included in patient’s 
standard of care practices.  Bisphosphonates should also be researched further to 
determine if the drug could be an effective supplemental therapy. 
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APPENDIX 
 
 
Table 7: Fetal Anomalies Associated with Polyhydraminos (Houben & Curry, 2008) 
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Table 8: Abnormalities Associated with an Absent/Small Fetal Stomach Bubble on 
Sonography (Houben & Curry, 2008) 
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